Jankova Lucy, Dent Owen F, Chan Charles, Chapuis Pierre, Clarke Stephen J
Bill Walsh Translational Cancer Research Laboratory, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
BMC Cancer. 2013 Oct 1;13:442. doi: 10.1186/1471-2407-13-442.
The preoperative ratio of neutrophils to lymphocytes (NLR) has been proposed as a marker of poor outcome in patients having a resection for colorectal cancer (CRC). This study investigated the association between NLR and overall survival, cancer-specific survival and recurrent cancer in patients who had a potentially curative resection for node-positive CRC.
Data on 322 patients were drawn from a prospectively recorded registry operated on between 1999 and 2007. Analyses of survival involved the Kaplan-Meier method, Cox regression and competing risks Cox regression.
Increasing NLR as a continuous variable was independently though weakly associated with diminishing overall survival after adjustment for other prognostic variables (HR 1.06, 95% CI 1.01-1.11, p = 0.013). Receiver operating characteristic analysis to dichotomize NLR as a predictor of overall survival yielded relatively poor sensitivity (55%), specificity (66%) and positive predictive value (56%, CI 47%-64%). Competing risks regression also showed that NLR was not independently associated with recurrence at any site (HR 1.04, CI 0.97-1.11, p = 0.241) or CRC-specific mortality (HR 1.02, CI 0.92-1.12, p = 0.782) but was associated with non-CRC mortality (HR 1.09, CI 1.03-1.15, p = 0.004).
In patients with stage C tumor the weak link between NLR and overall mortality was not specific to CRC but apparently arose because patients with an elevated inflammatory status preoperatively were likely to progress to earlier death but not necessarily because of their cancer.
术前中性粒细胞与淋巴细胞比值(NLR)已被提出作为接受结直肠癌(CRC)切除术患者预后不良的一个指标。本研究调查了NLR与接受潜在根治性切除术的淋巴结阳性CRC患者的总生存期、癌症特异性生存期和复发性癌症之间的关联。
从1999年至2007年进行的前瞻性记录登记中提取了322例患者的数据。生存分析采用Kaplan-Meier法、Cox回归和竞争风险Cox回归。
在对其他预后变量进行调整后,NLR作为连续变量增加与总生存期缩短独立相关,但相关性较弱(风险比1.06,95%置信区间1.01-1.11,p = 0.013)。将NLR作为总生存期预测指标进行二分的受试者工作特征分析显示,其敏感性(55%)、特异性(66%)和阳性预测值(56%,置信区间47%-64%)相对较差。竞争风险回归还显示,NLR与任何部位的复发(风险比1.04,置信区间0.97-1.11,p = 0.241)或CRC特异性死亡率(风险比1.02,置信区间0.92-1.12,p = 0.782)无独立关联,但与非CRC死亡率相关(风险比1.09,置信区间1.03-1.15,p = 0.004)。
在C期肿瘤患者中,NLR与总死亡率之间的弱关联并非CRC所特有,显然是因为术前炎症状态升高的患者可能更早死亡,但不一定是因为癌症。